Perrigo acquires U.K. firm Galpharm
This article was originally published in The Tan Sheet
Executive Summary
The Allegan, Mich.-based private labeler announces Jan. 9 the $86 million acquisition of Galpharm Healthcare Ltd, an OTC store-brand drug supplier based in Yorkshire, U.K. Perrigo says it anticipates adding $55 million to its sales annually. The acquisition "further expands our global presence" and "complements our existing U.K. business," Perrigo Chairman and CEO Joseph Papa says in a release...